Riham Mohamed Aly
Riham Mohamed Aly
Recent research reporting successful translation of stem cell therapies to patients have enriched the hope that such regenerative strategies may one day become a treatment for a wide range of vexing diseases. In fact, the past few years wit...
Mohamed A Rowisha,Mohamed R El-Shanshory,Eslam E El-Hawary et al.
Mohamed A Rowisha et al.
Background: The achievement of optimal number of CD34+ umbilical cord stem cells is essential for successful umbilical cord stem cell transplantation. So the aim of this study was to assess the potential effect of both ma...
CD44 expression in stem cells and niche microglia/macrophages following ischemic stroke [0.03%]
缺血性卒中后干细胞和生态位小胶质细胞/巨噬细胞中的CD44表达
Rikako Sawada,Akiko Nakano-Doi,Tomohiro Matsuyama et al.
Rikako Sawada et al.
Background: CD44, an adhesion molecule in the hyaluronate receptor family, plays diverse and important roles in multiple cell types and organs. Increasing evidence is mounting for CD44 expression in various types of stem ...
Safety and efficacy of stem cell therapy for treatment of neural damage in patients with multiple sclerosis [0.03%]
干细胞治疗多发性硬化神经损伤的安氏和疗效分析
Mohammadmahdi Jafarzadeh Bejargafshe,Mohammad Hedayati,Sahar Zahabiasli et al.
Mohammadmahdi Jafarzadeh Bejargafshe et al.
Multiple sclerosis (MS) is a multifocal inflammatory disease that involves the central nervous system and associated with limbs paralysis and serious problems in sensation, limbs, visual and sphincter. This disease is a result of autoimmune...
Evaluation of platelet-rich plasma from diabetic donors shows increased platelet vascular endothelial growth factor release [0.03%]
糖尿病供体富血小板血浆的评估显示血小板血管内皮生长因子释放增加
Karina,Komang Ardi Wahyuningsih,Siti Sobariah et al.
Karina et al.
Background: Platelet-rich plasma (PRP) contains pro-angiogenic growth factors including vascular endothelial growth factor (VEGF). Angiogenesis is a necessary component of wound healing in instances of diabetic foot ulcer...
Survival analysis of multiple myeloma patients after autologous stem cell transplantation [0.03%]
自体干细胞移植后多发性骨髓瘤患者的生存分析研究论文
Ju Li,Yan Zhu
Ju Li
Background: Hematopoietic stem cell transplantation has been applied to treat the hematologic malignancies since the 1980s. However, allogenic transplantation has inherent complications such as graft-versus-host disease a...
Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow derived stem cells in the treatment of Dominant Optic Atrophy [0.03%]
间充质干细胞治疗视神经萎缩临床试验的初步报告
Jeffrey N Weiss,Steven Levy
Jeffrey N Weiss
Background: We report the results of 6 patients with Dominant Optic Atrophy (DOA) who met inclusion criteria and were treated in the Stem Cell Ophthalmology Treatment Study (SCOTS). SCOTS/SCOTS 2 is an Institutional Revie...
Application of the CARE guideline as reporting standard in the Stem Cell Investigation [0.03%]
CARE指南在干细胞研究中的应用
Editorial Office
Editorial Office
Simona Pagliuca,Annalisa Ruggeri,Régis Peffault de Latour
Simona Pagliuca
Hematopoietic stem cell transplantation (HSCT) and immunosuppressive therapy (IST) represent the milestones of the treatment algorithm for idiopathic and inherited bone marrow failure (BMF) disorders. However, patients lacking a suitable do...
Gholam Basati,Mojtaba Khaksarian,Saber Abbaszadeh et al.
Gholam Basati et al.
Cancer stem cells (CSCs) are currently known as the main cause of tumor recurrence. After chemotherapy is completed, CSCs proliferate and then differentiate to generate new tumor tissues. Similar to normal stem cells, this non-uniformly dis...